We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NYR market cap is 16.51M. The company's latest EPS is AUD and P/E is N/A.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 1.13M | 2.34M | 1.11M | 1.58M | 3.4M |
Operating Income | -5.63M | -3.53M | -3.96M | -7.78M | -1.39M |
Net Income | -5.77M | -3.54M | -3.96M | -7.78M | -1.39M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 6.27M | 15.16M | 12.01M | 5.17M | 5.91M |
Total Liabilities | 740k | 665k | 515k | 907k | 855k |
Total Equity | 5.53M | 14.49M | 11.5M | 4.26M | 5.05M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -4.41M | -2.77M | -2.92M | -7.2M | -766k |
Investing | -3k | -5k | -5k | N/A | N/A |
Financing | 8.48M | 11.34M | -269k | N/A | 1.83M |
Market Cap | 16.51M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 179.41M |
Average Volume (1 week) | 537.56k |
Average Volume (1 Month) | 340.01k |
52 Week Change | 268.00% |
52 Week High | 0.17 |
52 Week Low | 0.018 |
Spread (Intraday) | 0.01 (10.53%) |
Company Name | Nyrada Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions